High dose erythropoietin may not be efficacious for neuroprotection in extremely preterm infants
1. In this randomized controlled trial involving extremely preterm infants, high dose erythropoietin did not reduce the risk of death...
1. In this randomized controlled trial involving extremely preterm infants, high dose erythropoietin did not reduce the risk of death...
1. In this double-blind phase 2a trial, cathepsin K inhibitor MIV-711 did not show a significant benefit in reducing pain...
1. In this prospective cohort study involving patients who had inpatient noncardiac surgery, those with N-terminal pro-B-type natriuretic peptide (NT-proBNP)...
1. After a 3-year follow-up to a phase 3 trial, the epidermal growth factor receptor-tyrosine kinase inhibitor osimertinib resulted in...
1. In this retrospective study involving South Koreans with no history of major adverse cardiovascular events (MACE), persons who developed...
1. In this randomized trial involving HIV-negative African adults with latent tuberculosis, vaccination with M72/AS01E provoked an immune response and...
1. In this randomized controlled trial, patients with type 1 diabetes who used a closed-loop system spent a greater percentage...
1. In this phase 3 trial, patients with relapsed or refractory acute myeloid leukemia who received gilteritinib had a longer...
1. In this multicenter, phase 3 study of cystic fibrosis patients who were previously unresponsive to modulator regimens, triple-combination therapy...
1. In this phase 3 trial, patients with fibrosing lung disease who received nintedanib experienced a much slower rate of...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.